A

Ardelyx

D
ARDX
USD
-0.11
(-1.6936%)
Market Closed
122,348.00
Volume
-0.27
EPS
-
Div Yield
-23.648148
P/E
1,503,208,948.46
Market Cap
Today
11.8214%
1 Week
8.681%
1 Month
4.330%
6 Months
-31.270%
12 Months
56.880%
Year To Date
3.234%
All Time
-50.311%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
D
DVAX
-0.29
(-2.3577%)
USD
A
ADMP
(%)
USD
Z
ZYNE
(%)
USD
B
BPMC
1.79
(1.7956%)
USD
C
CRBP
-0.59
(-3.0809%)
USD
G
GTHX
0.01
(0.1399%)
USD
ALNY
ALNY
-0.795
(-0.2913%)
USD
V
VKTX
2.97
(4.5075%)
USD
G
GLMD
0
(0%)
USD

Title:
Ardelyx

Sector:
Healthcare
Industry:
Biotechnology
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
Do you need help or have a question?
Contact Us